免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

cobas SARS-CoV-2 定性检测,适用于 cobas 5800/6800/8800 系统

K号: K231306 · 2023-06-01

决定日期2023-06-01
产品代码QQX
咨询委员会抱歉,您提供的内容“MI”不足以进行翻译。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。
决定实质等同

器械摘要

cobas SARS-CoV-2 Qualitative for use on the cobas 5800/6800/8800 Systems is the device name listed in this FDA 510(k) record. The listed applicant is Roche Molecular Systems, Inc.. It received FDA 510(k) clearance on 2023-06-01 under 510(k) number K231306. The device is classified under product code QQX. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the cobas SARS-CoV-2 Qualitative for use on the cobas 5800/6800/8800 Systems?

cobas SARS-CoV-2 Qualitative for use on the cobas 5800/6800/8800 Systems is a medical device that received FDA 510(k) clearance on 2023-06-01. The listed applicant is Roche Molecular Systems, Inc.. The 510(k) number is K231306.

When did cobas SARS-CoV-2 Qualitative for use on the cobas 5800/6800/8800 Systems receive FDA 510(k) clearance?

cobas SARS-CoV-2 Qualitative for use on the cobas 5800/6800/8800 Systems received FDA 510(k) clearance on 2023-06-01, under 510(k) number K231306.

Who is the listed applicant for cobas SARS-CoV-2 Qualitative for use on the cobas 5800/6800/8800 Systems?

FDA 510(k)记录中列出罗氏分子系统有限公司为申请人。这本身并不足以确立该设备制造商的身份。

What is the FDA product code for cobas SARS-CoV-2 Qualitative for use on the cobas 5800/6800/8800 Systems?

The FDA product code for cobas SARS-CoV-2 Qualitative for use on the cobas 5800/6800/8800 Systems is QQX.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Roche Molecular Systems, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

查看所有 36 个设备 →

相关器械(代码:QQX)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑